Therapeutics – MicroVibeNews

星期五, 6月 5, 2026

Sarepta Therapeutics, Inc. 2025 Q4 – Results – Earnings Call Presentation

Sarepta Therapeu…

Summit Therapeutics Inc. (SMMT) Q4 2025 Earnings Call Transcript

Summit Therapeut…

Halozyme Therapeutics, Inc. (HALO) Q4 2025 Earnings Call Transcript

Halozyme Therape…

Viking Therapeutics: Buyers Are Quietly Accumulating On Its Obesity Drugs Launch Potential

Viking Therapeut…

Spero Therapeutics: Tebipenem's FDA Path Supports A Speculative Buy

Spero Therapeuti…

Seres Therapeutics: Strong SER-155 Data, But Dilution Risk Now Warrants A 'Hold'

Seres Therapeuti…

United Therapeutics: In Progress — New Organs For Old At Scale

United Therapeut…

Cullinan Therapeutics: Cash-Rich Biotech With Multiple Value Drivers

Cullinan Therape…

Viridian Therapeutics: Cautious Optimism As Key Milestones Approach (Rating Downgrade)

Viridian Therape…

TG Therapeutics: The "Exit Velocity" You Can't Ignore (Rating Upgrade)

TG Therapeutics:…

Lexeo Therapeutics, Inc. (LXEO) Presents at 44th Annual J.P. Morgan Healthcare Conference – Slideshow

Lexeo Therapeuti…

Denali Therapeutics Inc. (DNLI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Denali Therapeut…

Protagonist Therapeutics, Inc. (PTGX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Protagonist Ther…

Nurix Therapeutics, Inc. (NRIX) Presents at 44th Annual J.P. Morgan Healthcare Conference – Slideshow

Nurix Therapeuti…

Nurix Therapeutics, Inc. (NRIX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Nurix Therapeuti…

Jasper Therapeutics, Inc. (JSPR) Discusses Updated Data from BEACON and Open-Label Extension Studies in Chronic Urticaria – Slideshow

Jasper Therapeut…

Aquestive Therapeutics: Looking For The PDUFA Run-Up

Aquestive Therap…

Why Corcept Therapeutics’ Relacorilant Fell Short And What It Means For The Company

This article was…

Neumora Therapeutics, Inc. (NMRA) Discusses Positive Phase 1b Results for NMRA-511 in Alzheimer's Disease Agitation – Slideshow

Neumora Therapeu…

Viking Therapeutics: The Obesity Drugs Gold Rush Is Far From Over

Viking Therapeut…

Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains

Galectin Therape…

Nektar Therapeutics (NKTR) Discusses Topline Results From REZOLVE-AA Phase 2b Study of rezpegaldesleukin in Alopecia Areata – Slideshow

Nektar Therapeut…